Cargando…
Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study
BACKGROUND: For causal treatment by allergy immunotherapy (AIT) a single or few allergen products for the clinically most relevant allergens are applied to treat multiple allergies, but few data on the tolerability of multiple AIT applications are available. OBJECTIVE: The aim of our study was to in...
Autores principales: | Reiber, Rainer, Wolf, Hendrik, Schnitker, Jörg, Wüstenberg, Eike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332307/ https://www.ncbi.nlm.nih.gov/pubmed/28070824 http://dx.doi.org/10.1007/s40801-016-0103-4 |
Ejemplares similares
-
Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study
por: Reiber, Rainer, et al.
Publicado: (2016) -
Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration
por: Schwab, Jan-Alexander, et al.
Publicado: (2013) -
Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study
por: Schwab, Jan-Alexander, et al.
Publicado: (2018) -
Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study
por: Horn, Andreas, et al.
Publicado: (2016) -
Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome: An Observational Study
por: Bergmann, Karl-Christian, et al.
Publicado: (2008)